The	0	3	O
Down	4	8	B-Gene_or_gene_product
syndrome	9	17	I-Gene_or_gene_product
critical	18	26	I-Gene_or_gene_product
region	27	33	I-Gene_or_gene_product
gene	34	38	I-Gene_or_gene_product
1	39	40	I-Gene_or_gene_product
short	41	46	O
variant	47	54	O
promoters	55	64	O
direct	65	71	O
vascular	72	80	B-Multi-tissue_structure
bed	81	84	I-Multi-tissue_structure
-	84	85	O
specific	85	93	O
gene	94	98	O
expression	99	109	O
during	110	116	O
inflammation	117	129	O
in	130	132	O
mice	133	137	B-Organism
.	137	138	O

Down	140	144	B-Gene_or_gene_product
syndrome	145	153	I-Gene_or_gene_product
critical	154	162	I-Gene_or_gene_product
region	163	169	I-Gene_or_gene_product
gene	170	174	I-Gene_or_gene_product
1	175	176	I-Gene_or_gene_product
(	177	178	O
DSCR	178	182	B-Gene_or_gene_product
-	182	183	I-Gene_or_gene_product
1	183	184	I-Gene_or_gene_product
)	184	185	O
short	186	191	O
variant	192	199	O
(	200	201	O
DSCR	201	205	B-Gene_or_gene_product
-	205	206	I-Gene_or_gene_product
1s	206	208	I-Gene_or_gene_product
)	208	209	O
is	210	212	O
an	213	215	O
inhibitor	216	225	O
of	226	228	O
calcineurin	229	240	B-Gene_or_gene_product
/	240	241	O
NFAT	241	245	B-Gene_or_gene_product
signaling	246	255	O
encoded	256	263	O
by	264	266	O
exons	267	272	O
4	273	274	O
-	274	275	O
7	275	276	O
of	277	279	O
DSCR1	280	285	B-Gene_or_gene_product
.	285	286	O

We	287	289	O
previously	290	300	O
reported	301	309	O
that	310	314	O
VEGF	315	319	B-Gene_or_gene_product
induces	320	327	O
DSCR	328	332	B-Gene_or_gene_product
-	332	333	I-Gene_or_gene_product
1s	333	335	I-Gene_or_gene_product
expression	336	346	O
in	347	349	O
endothelial	350	361	B-Cell
cells	362	367	I-Cell
,	367	368	O
which	369	374	O
in	375	377	O
turn	378	382	O
negatively	383	393	O
feeds	394	399	O
back	400	404	O
to	405	407	O
attenuate	408	417	O
endothelial	418	429	B-Cell
cell	430	434	I-Cell
activation	435	445	O
.	445	446	O

Here	447	451	O
,	451	452	O
in	453	455	O
order	456	461	O
to	462	464	O
characterize	465	477	O
the	478	481	O
role	482	486	O
of	487	489	O
the	490	493	O
promoter	494	502	O
that	503	507	O
drives	508	514	O
DSCR	515	519	B-Gene_or_gene_product
-	519	520	I-Gene_or_gene_product
1s	520	522	I-Gene_or_gene_product
expression	523	533	O
in	534	536	O
mediating	537	546	O
inducible	547	556	O
expression	557	567	O
in	568	570	O
vivo	571	575	O
and	576	579	O
to	580	582	O
determine	583	592	O
the	593	596	O
functional	597	607	O
relevance	608	617	O
of	618	620	O
DSCR	621	625	B-Gene_or_gene_product
-	625	626	I-Gene_or_gene_product
1s	626	628	I-Gene_or_gene_product
in	629	631	O
inflammation	632	644	O
,	644	645	O
we	646	648	O
targeted	649	657	O
a	658	659	O
DNA	660	663	O
construct	664	673	O
containing	674	684	O
1	685	686	O
.	686	687	O
7	687	688	O
kb	689	691	O
of	692	694	O
the	695	698	O
human	699	704	B-Organism
DSCR1s	705	711	B-Gene_or_gene_product
promoter	712	720	O
coupled	721	728	O
to	729	731	O
the	732	735	O
lacZ	736	740	B-Gene_or_gene_product
reporter	741	749	O
to	750	752	O
the	753	756	O
hypoxanthine	757	769	B-Gene_or_gene_product
guanine	770	777	I-Gene_or_gene_product
phosphoribosyl	778	792	I-Gene_or_gene_product
transferase	793	804	I-Gene_or_gene_product
(	805	806	O
Hprt	806	810	B-Gene_or_gene_product
)	810	811	O
locus	812	817	O
of	818	820	O
mice	821	825	B-Organism
.	825	826	O

We	827	829	O
determined	830	840	O
that	841	845	O
lacZ	846	850	B-Gene_or_gene_product
was	851	854	O
uniformly	855	864	O
expressed	865	874	O
in	875	877	O
the	878	881	O
endothelium	882	893	B-Tissue
of	894	896	O
transgenic	897	907	B-Developing_anatomical_structure
embryos	908	915	I-Developing_anatomical_structure
but	916	919	O
was	920	923	O
markedly	924	932	O
downregulated	933	946	O
postnatally	947	958	O
.	958	959	O

Systemic	960	968	O
administration	969	983	O
of	984	986	O
VEGF	987	991	B-Gene_or_gene_product
or	992	994	O
LPS	995	998	B-Drug_or_compound
in	999	1001	O
adult	1002	1007	O
mice	1008	1012	B-Organism
resulted	1013	1021	O
in	1022	1024	O
cyclosporine	1025	1037	B-Drug_or_compound
A	1038	1039	I-Drug_or_compound
-	1039	1040	O
sensitive	1040	1049	O
reactivation	1050	1062	O
of	1063	1065	O
the	1066	1069	O
DSCR1s	1070	1076	B-Gene_or_gene_product
promoter	1077	1085	B-DNA_domain_or_region
and	1086	1089	O
endogenous	1090	1100	O
gene	1101	1105	O
expression	1106	1116	O
in	1117	1119	O
a	1120	1121	O
subset	1122	1128	O
of	1129	1131	O
organs	1132	1138	B-Organ
,	1138	1139	O
including	1140	1149	O
the	1150	1153	O
heart	1154	1159	B-Organ
and	1160	1163	O
brain	1164	1169	B-Organ
.	1169	1170	O

The	1171	1174	O
DSCR1s	1175	1181	B-Gene_or_gene_product
promoter	1182	1190	B-DNA_domain_or_region
was	1191	1194	O
similarly	1195	1204	O
induced	1205	1212	O
in	1213	1215	O
the	1216	1219	O
endothelium	1220	1231	B-Tissue
of	1232	1234	O
tumor	1235	1240	B-Pathological_formation
xenografts	1241	1251	O
.	1251	1252	O

In	1253	1255	O
a	1256	1257	O
mouse	1258	1263	B-Organism
model	1264	1269	O
of	1270	1272	O
endotoxemia	1273	1284	O
,	1284	1285	O
DSCR	1286	1290	B-Gene_or_gene_product
-	1290	1291	I-Gene_or_gene_product
1s	1291	1293	I-Gene_or_gene_product
-	1293	1294	O
deficient	1294	1303	O
mice	1304	1308	B-Organism
demonstrated	1309	1321	O
increased	1322	1331	O
sepsis	1332	1338	O
mortality	1339	1348	O
,	1348	1349	O
whereas	1350	1357	O
adenovirus	1358	1368	B-Organism
-	1368	1369	O
mediated	1369	1377	O
DSCR	1378	1382	B-Gene_or_gene_product
-	1382	1383	I-Gene_or_gene_product
1s	1383	1385	I-Gene_or_gene_product
overexpression	1386	1400	O
protected	1401	1410	O
against	1411	1418	O
LPS	1419	1422	B-Drug_or_compound
-	1422	1423	O
induced	1423	1430	O
lethality	1431	1440	O
.	1440	1441	O

Collectively	1442	1454	O
,	1454	1455	O
these	1456	1461	O
data	1462	1466	O
suggest	1467	1474	O
that	1475	1479	O
the	1480	1483	O
DSCR1s	1484	1490	B-Gene_or_gene_product
promoter	1491	1499	B-DNA_domain_or_region
directs	1500	1507	O
vascular	1508	1516	B-Multi-tissue_structure
bed	1517	1520	I-Multi-tissue_structure
-	1520	1521	O
specific	1521	1529	O
expression	1530	1540	O
in	1541	1543	O
activated	1544	1553	O
endothelium	1554	1565	B-Tissue
and	1566	1569	O
that	1570	1574	O
DSCR	1575	1579	B-Gene_or_gene_product
-	1579	1580	I-Gene_or_gene_product
1s	1580	1582	I-Gene_or_gene_product
serves	1583	1589	O
to	1590	1592	O
dampen	1593	1599	O
the	1600	1603	O
host	1604	1608	O
response	1609	1617	O
to	1618	1620	O
infection	1621	1630	O
.	1630	1631	O

